Menu ×


3D Printed Drugs Market : Global Demand Analysis & Opportunity Outlook 2024

  • Report ID: 421
  • Text Size:

Extensive insights into the Growth of 3D Printed Drugs Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

3D Printed Drugs Market Overview button

3D printed drugs are developed by using powder-liquid three dimensional (3DP) printing technologies. This technique uses an aqueous fluid which is able to bind different or similar layer of powders and produces multiple type of products. Drugs or Pills made by powder-liquid three dimensional techniques are comparatively more soluble than other drugs or pills. Additionally, 3D printed drugs are able to dissolve insoluble compounds such as silver chloride very easily. Moreover, 3D printed high dose drugs can be dissolve within few seconds that makes 3D printed drugs more acceptable. Moreover, 3D printed drugs are comparatively reliable pills in very right dosages.

Market Size & Forecast

Global 3D printed drugs market is anticipated to flourish over the forecast period i.e. 2017-2024. Rising health diseases across the globe and rising demand for cheaper drugs or pills are some of the major factors which are likely to bolster the growth of global 3D printed drugs market during the forecast period.

In terms of region, global 3D printed drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, North America is expected to dominate the global market of 3D printed drugs owing to factors such as rising number of chronic diseases and growing adoption of technological advancements and increasing geriatric population in this region.

3d Printed drugs market

Additionally, Asia Pacific region is expected to be fastest growing market for 3D printed drugs during the forecast period. Factors such as rapid development of healthcare infrastructure and increasing investment in research and development of healthcare sector are envisioned to bolster the growth of 3D printed drugs market in this region. Moreover, Europe region is expected to witness satisfactory growth over the forecast period. This growth of 3D printed drugs market in this region can be attributed to factors such as growing health consciousness among people of this region.CLICK TO DOWNLOAD FREE SAMPLE

Market Segmentation

Our-in depth analysis of the global 3D printed drugs market includes the following segments:

By End User

  • Hospitals
  • Clinics
  • Research Laboratories

By Region

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers & Challenges

Growth of global 3D printed drugs market was initially driven by factors such as rising health related diseases and growing geriatric population all across the globe. Further, advantages of 3D printed drugs over general drugs such as low cost and better solubility are making 3D printed drugs more acceptable for patients from all over the world. Moreover, these advantages of 3D printed drugs are expected to drive the growth of global 3D printed drugs market.

3D printed drugs are better solution for those patients who respond to the same drugs or pills in different way. Moreover, 3D printed drugs allow doctors or pharmacist to use every patient’s individual information such as age and type of diseases and give them precise medication dose accordingly. Such benefits of 3D printed drugs are envisioned to drive the growth of 3D printed drugs market. 

Technological advancement in healthcare sector is also a major factor which is anticipated to bolster the demand for 3D printed drugs in near future. 3D printed drugs can be produced with precise amount of dose according to the requirement of patients. Furthermore, 3D printed drugs can perform multiple treatments with a single pill. Such functions of 3D printed drugs are expected to drive the growth of global 3D printed drugs market. However, lack of approval of 3D printed drugs in many countries is a major factor which may restrict the production of such drugs in future. Additionally, lack of user instruction and need for right packaging are some of the major challenges which are projected to dampen the growth of global 3D printed drugs market.

Key Players

The major players for 3D printed drugs market are as follows:

  • Aprecia
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financial

Key potential companies that may enter into manufacturing of 3D printed drugs are mentioned below:

  • Extend Biosciences
  • Bioduro
  • Affinity Therapeutics
  • Osmotica Pharmaceuticals
  • Acrux
  • Thiomatrix
  • Ico Therapeutics Inc.
  • Formac Pharmaceuticals
  • BiopharmX
  • Pacira Pharmaceuticals Inc.


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved